Diseases of the Colon & Rectum

, Volume 44, Issue 3, pp 405–409 | Cite as

Conservative treatment of acute thrombosed external hemorrhoids with topical nifedipine

  • Pasquale Perrotti
  • Carmine Antropoli
  • Domenico Molino
  • Guglielmo De Stefano
  • Massimo Antropoli
Original Contributions


PURPOSE: This study was performed according to a prospective, randomized, open design. The aim was to test the efficacy of local application of nifedipine ointment in healing acute thrombosed external hemorrhoids. METHODS: Ninety-eight patients who gave their informed consent were recruited; they received clinical examination and anoscopy. A questionnaire to evaluate symptoms, pain, and concurrent use of analgesics was administered. Patients treated with nifedipine (n=50) used topical 0.3 percent nifedipine and 1.5 percent lidocaine ointment every 12 hours for two weeks. The control group, consisting of 48 patients, received topical 1.5 percent lidocaine ointment during therapy. RESULTS: Results obtained were as follows: complete relief of pain in 43 patients (86 percent) of the nifedipine-treated group as opposed to 24 patients (50 percent) of the control group after 7 days of therapy (P < 0.01); oral analgesics were used by 4 patients (8 percent) in the nifedipine-treated group as opposed to 26 patients (54.1 percent) of the control group after 7 days of therapy (P < 0.01); and resolution of acute thrombosed external hemorrhoids was achieved after 14 days of therapy in 46 patients (92 percent) of the nifedipine-treated group, as opposed to 22 patients (45.8 percent) of the control group (P < 0.01). We did not observe any systemic side effect in patients treated with nifedipine. CONCLUSIONS: Our study clearly demonstrates that the use of topical nifedipine, which at present is for treatment of cardiovascular disorders, is a reliable new option in the conservative treatment of thrombosed external hemorrhoids.

Key words

Hemorrhoids Methods of treatment Nifedipine 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cohen Z. Symposium on outpatient anorectal procedures. Alternatives to surgical hemorrhoidectomy. Can J Surg 1985;28:230–1.Google Scholar
  2. 2.
    Thomson WH. The nature of haemorrhoids. Br J Surg 1975;62:542–52.Google Scholar
  3. 3.
    Thomson JP, Akwary OE. Disorders of the anal canal. In: Sabiston DC Jr, ed. Textbook of surgery: the biological basis of modern surgical practice. 14th ed. Philadelphia: WB Saunders, 1991:958–72.Google Scholar
  4. 4.
    Haas PA, Fox TA Jr, Haas GP. The pathogenesis of hemorrhoids. Dis Colon Rectum 1984;27:442–50.Google Scholar
  5. 5.
    Oh C. Acute thrombosed external hemorrhoids. Mt Sinai J Med 1989;56:30–2.Google Scholar
  6. 6.
    Schussman LC, Lutz LJ. Outpatient management of hemorrhoids. Primary Care 1986;13:527–41.Google Scholar
  7. 7.
    Goldberg SM, Nivatvongs S, Rothenberger DA. Colon, rectum, and anus. In: Schwartz SI, ed. Principles of surgery, 5th ed. New York: McGraw Hill, 1989:1225–314.Google Scholar
  8. 8.
    Gorfine SR. Treatment of benign anal disease with topical nitroglycerin. Dis Colon Rectum 1995;38:453–7.Google Scholar
  9. 9.
    Chrysos E, Xynos E, Tzovaras G, Zoras OJ, Tsiaoussis J, Vassilakis SJ. Effect of nifedipine on rectoanal motility. Dis Colon Rectum 1996;39:212–6.Google Scholar
  10. 10.
    Cook TA, Brading AF, Mortensen NJ. Differences in contractile properties of anorectal smooth muscle and the effects of calcium channel blockade. Br J Surg 1999;86:70–5.Google Scholar
  11. 11.
    Cook TA, Brading AF, Mortensen NJ. Effects of nifedipine on anorectal smooth musclein vitro. Dis Colon Rectum 1999;42:782–7.Google Scholar
  12. 12.
    Antropoli C, Perrotti P, Rubino M,et al. Nifedipine for local use in conservative treatment of anal fissures: preliminary results of a multicenter study. Dis Colon Rectum 1999;42:1011–5.Google Scholar
  13. 13.
    Cook TA, Smilgin Humphreys MM, Mortensen NJ. Oral nifedipine reduces resting anal pressure and heals chronic anal fissures. Br J Surg 1999;86:1269–73.Google Scholar
  14. 14.
    The Standards Task Force, American Society of Colon, and Rectal Surgeons. Practice parameters for the treatment of hemorrhoids. Dis Colon Rectum 1993;36:1118–20.Google Scholar
  15. 15.
    Lund JN, Scholefield JH. A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure. Lancet 1997;349:11–4.Google Scholar
  16. 16.
    Dorfman G, Levitt M, Platell C. Treatment of chronic anal fissure with topical glyceryl trinitrate. Dis Colon Rectum 1999;42:1007–10.Google Scholar
  17. 17.
    Bleday R, Pena JP, Rothenberger DA, Goldberg SM, Buls JG. Symptomatic hemorrhoids: current incidence and complications of operative therapy. Dis Colon Rectum 1992;35:477–81.Google Scholar
  18. 18.
    Eisenstat T, Salvati EP, Rubin RJ. The outpatient management of acute hemorrhoidal disease. Dis Colon Rectum 1979;22:315–7.Google Scholar
  19. 19.
    Müller-Lobeck H. Gradual conservative treatment of haemorrhoids. Colo-proctology 1993;1:4–8.Google Scholar
  20. 20.
    Thanapongsathorn W, Vajrabukka T. Clinical trial of oral diosmin (Daflon®) in the treatment of hemorrhoids. Dis Colon Rectum 1992;35:1085–8.Google Scholar
  21. 21.
    Triggle DJ. Calcium, calcium channels, and calcium channel antagonists. Can J Physiol Pharmacol 1990;68:1474–81.Google Scholar
  22. 22.
    Arabi Y, Alexander-Williams J, Keighley MR. Anal pressures in hemorrhoids and anal fissure. Am J Surg 1977;134:608–10.Google Scholar
  23. 23.
    Lin JK. Anal manometric studies in hemorrhoids and anal fissures. Dis Colon Rectum 1989;32:839–42.Google Scholar
  24. 24.
    Morgado PJ, Suarez JA, Gomez LG, Morgado PJ Jr. Histoclinical basis for a new classification of hemorrhoidal disease. Dis Colon Rectum 1988;31:474–80.Google Scholar
  25. 25.
    Katoh N, Hirano S, Kishimoto S, Yasuno H. Calcium channel blockers suppress the contact hypersensitivity reaction (CHR) by inhibiting antigen transport and presentation by epidermal Langerhans cells in mice. Clin Exp Immunol 1997;108:302–8.Google Scholar
  26. 26.
    Oshiro H, Kobayashi I, Kim D, Takenaka H, Hobson RW 2nd, Duran WN. L-type calcium channel blockers modulate the microvascular hyperpermeability induced by platelet-activating factor in vivo. J Vasc Surg 1995;22:723–39.Google Scholar
  27. 27.
    Landau AJ, Eberhardt RT, Frishman WH. Intranasal delivery of cardiovascular agents: an innovative approach to cardiovascular pharmacotherapy. Am Heart J 1994;127:1594–9.Google Scholar

Copyright information

© The American Society of Colon and Rectal Surgeons 2001

Authors and Affiliations

  • Pasquale Perrotti
    • 1
  • Carmine Antropoli
    • 2
  • Domenico Molino
    • 2
  • Guglielmo De Stefano
    • 3
  • Massimo Antropoli
    • 4
  1. 1.From the Emergency Surgery DepartmentA. Cardarelli HospitalItaly
  2. 2.Divisione VII: Chirurgia GastroenterologicaA. Cardarelli HospitalItaly
  3. 3.Cattedra di Chirurgia Generale“Federico II” University of Naples, School of MedicineItaly
  4. 4.Istituto di Anatomia Chirurgica e Corso di OperazioniII University of Naples, School of MedicineNaplesItaly

Personalised recommendations